CD8A and neoplasm: The presence of these ligands within a metastatic lesion together with the upregulation of the inhibitory receptors on the tumor-specific CD8 T-cells fits well with the previously described functional deficiency [42] and the exhaustion profile exhibited by tumor-specific T-cells in metastatic lesions [1].